2019 Vol.37, N°5 - Suppl.120 - Table of contents

New concepts in osteoarthritis

purchase complete issue

Introduction

CER12863
2019,37,5,Suppl.120
Pg. 0002

Free to view

New concepts in osteoarthritis
A.-M. Malfait, T. Pincus

Epidemiology

CER12785
2019,37,5,Suppl.120
Pg. 0003-0006

Free to view

Osteoarthritis is a serious disease
G.A. Hawker

CER12800
2019,37,5,Suppl.120
Pg. 0007-0017

Free to view

Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease
T. Pincus, I. Castrejon, Y. Yazici, K.A. Gibson, M.J. Bergman, J.A. Block

CER12813
2019,37,5,Suppl.120
Pg. 0018-0023

Free to view

Low socioeconomic status and patient questionnaires in osteoarthritis: challenges to a “biomedical model” and value of a complementary “biopsychosocial model”
T. Pincus, I. Castrejon

CER12789
2019,37,5,Suppl.120
Pg. 0024-0030

Free to view

Knee and hip osteoarthritis as predictors of premature death: a review of the evidence
R.J. Cleveland, A.E. Nelson, L.F. Callahan

CER12748
2019,37,5,Suppl.120
Pg. 0031-0039

Free to view

Public Health Interventions for Osteoarthritis - updates on the Osteoarthritis Action Alliance’s efforts to address the 2010 OA Public Health Agenda Recommendations
L.F. Callahan, K.R. Ambrose, A.L. Albright, M. Altpeter, Y.M. Golightly, K.F. Huffman, A.E. Nelson, S.E. Weisner

Pathophysiology

CER12743
2019,37,5,Suppl.120
Pg. 0040-0047

Free to view

The function of microRNAs in cartilage and osteoarthritis
T.E. Swingler, L. Niu, P. Smith, P. Paddy, L. Le, M.J. Barter, D.A. Young, I.M. Clark

CER12605
2019,37,5,Suppl.120
Pg. 0048-0056

Free to view

Danger signals and inflammaging in osteoarthritis
M. Millerand, F. Berenbaum, C. Jacques

CER12757
2019,37,5,Suppl.120
Pg. 0057-0063

Free to view

Innate inflammation and synovial macrophages in osteoarthritis pathophysiology
T.M. Griffin, C.R. Scanzello

CER12718
2019,37,5,Suppl.120
Pg. 0064-0072

Free to view

Phenotypes of osteoarthritis: current state and future implications
L.A. Deveza, A.E. Nelson, R.F. Loeser

Measurement

CER12762
2019,37,5,Suppl.120
Pg. 0073-0087

Free to view

Biochemical markers in osteoarthritis with lessons learned from osteoporosis
M.A. Karsdal, K. Henriksen, A.C. Bay-Jensen

CER12778
2019,37,5,Suppl.120
Pg. 0088-0095

Free to view

Magnetic resonance imaging assessment of knee osteoarthritis: current and developing new concepts and techniques
D. Hayashi, F.W. Roemer, A. Guermazi

CER12717
2019,37,5,Suppl.120
Pg. 0096-0099

Free to view

Identifying pain susceptibility phenotypes in knee osteoarthritis
L.C. Carlesso, T. Neogi

CER12802
2019,37,5,Suppl.120
Pg. 0100-0111

Free to view

Patient questionnaires in osteoarthritis: what patients teach doctors about their osteoarthritis on a multidimensional health assessment questionnaire (MDHAQ) in clinical trials and clinical care
T. Pincus, J. Schmukler, I. Castrejon

Specific organs

CER12749
2019,37,5,Suppl.120
Pg. 0112-0117

Free to view

Physical therapy for patients with knee and hip osteoarthritis: supervised, active treatment is current best practice
S.T. Skou, E.M. Roos

CER12765
2019,37,5,Suppl.120
Pg. 0118-0123

Free to view

The powerful placebo effect in osteoarthritis
W. Zhang

CER12738
2019,37,5,Suppl.120
Pg. 0124-0129

Free to view

Treating osteoarthritis pain: recent approaches using pharmacological therapies
A. Ghouri, P.G. Conaghan

CER12781
2019,37,5,Suppl.120
Pg. 0130-0134

Free to view

The “elusive DMOAD”: Aggrecanase inhibition from laboratory to clinic
A.-M. Malfait, M.D. Tortorella

CER12727
2019,37,5,Suppl.120
Pg. 0135-0140

Free to view

Disease modification in osteoarthritis: are we there yet?
W.M. Oo, D.J. Hunter